Canine Leishmaniasis Management Market By Product Type (Canine leishmaniasis prevention, Canine leishmaniasis treatment), By Disease Type (Visceral leishmaniasis, Cutaneous leishmaniasis, Mucocutaneous leishmaniasis), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Veterinary clinics, Veterinary pharmacies, Online pharmacies, NGOs, Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Canine Leishmaniasis Management Market size was valued at USD x million in 2023 and is poised to grow at a CAGR of x% in 2024-2030. Canine leishmaniasis is an incurable multisystemic disease caused by the parasite, Leishmania infantum, which is transferred through the bite of a sandfly in tropical and subtropical countries, but direct transmission between dogs, and from pregnant dogs to their puppies, exists. 

The rising incidence of canine leishmaniasis plays a pivotal role in driving the revenues of the canine leishmaniasis management market. The incidence of canine leishmaniasis is rising gradually worldwide. For instance, research suggests that the highest estimated ranged from 50 to 100 cases per 1000 dogs annually and were concentrated in the southeastern and southwestern regions of Spain, as well as the Balearic Islands. This increased burden of this disease drives the demand for the development of advanced treatment and diagnosis options. Diagnosis of this disease is often determined via serology, with quantitative serologic tests such as immunofluorescence assays or ELISA as confirmation. Treatment options are limited but the major protocols used for the treatment of leishmaniasis in dogs include the use of N-methylglucamine antimoniate or Miltefosine in combination with allopurinol. Moreover, rising government regulations are another powerful driver of the canine leishmaniasis management market. As health concerns about animal increases across the globe, the government is imposing several strict guidelines, which in turn necessitate the development of canine leishmaniasis management options. A nonprofit scientific association, LeishVet, has created regulations, primarily designed to assist veterinary clinicians in the management of canine leishmaniosis by suggesting standardized and rational approaches to the diagnosis, treatment, follow-up, control, and prevention of canine leishmaniosis. This strict regulation ultimately drives the growth of the canine leishmaniosis management market.

However, factors such as limited treatment options and lack of awareness pose significant challenges to the growth of the canine leishmaniasis management market. Meanwhile, the rise in research and development activities presents a significant opportunity for the growth of the canine leishmaniasis management market. Several key manufacturers are announcing launches to strengthen their market position.

Global Canine Leishmaniasis Management Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

N/A

Largest Market

North America

Fastest Growing Market

North America
Canine Leishmaniasis Management Market Dynamics

The increasing pet ownership is a significant driver of growth in the canine leishmaniasis management market. As pet ownership across the world rises, the demand for concerns related to canine leishmaniasis disease increases, which in turn necessitates the development of advanced diagnosis and treatment options. As dogs are the main reservoir for this disease, pet owners are spending hugely to seek preventive measures to effectively manage leishmaniasis diseases in dogs, which boosts the demand for canine leishmaniasis management products. In addition, rising human health concerns are another major driver behind the growth of the canine leishmaniasis management market. Canine leishmaniasis, as it is a zoonotic disease, can be transferred to humans by a sandfly that has previously bitten an infected animal. Though this disease is not transferred directly from dog to human, it can play a crucial role in the transmission and spread of the parasite. It can have serious consequences if a human with a compromised immune system gets affected by leishmaniasis. Hence, using several repelllant and insecticides can prevent the bite of sandfly, which can ultimately protect both dogs and humans.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Canine Leishmaniasis Management Market Segmentation

By Product Type
  • Canine leishmaniasis prevention,
  • Canine leishmaniasis treatment
By Disease Type
  • Visceral leishmaniasis,
  • Cutaneous leishmaniasis,
  • Mucocutaneous leishmaniasis
By Route of Administration
  • Oral,
  • Parenteral,
  • Topical
By Distribution Channel
  • Veterinary clinics,
  • Veterinary pharmacies,
  • Online pharmacies,
  • NGOs,
  • Others

Frequently Asked Questions

The canine leishmaniasis management market is projected to expand at a CAGR of x% during the forecast period.

Zoetis, Inc. (Pfizer) (U.S), Hertape Calier Saude Animal S.A. (Brazil), Virbac AH Inc. (France), Laboratories Leti (Spain), Bioiberica S.A. (Spain)

Asia Pacific is the fastest-growing region for canine leishmaniasis management market

The increasing investment in veterinary care, rising pet ownership, and rising awareness of animal health provide potential opportunities for companies to enhance their revenue over the forecast years.

The rising focus on research and development activities to develop effective diagnosis and treatment solutions stands out as a significant trend within the canine leishmaniasis management market.

1. Executive Summary
2. Global Canine Leishmaniasis Management Market Introduction
2.1. Global Canine Leishmaniasis Management Market Taxonomy
2.2. Global Canine Leishmaniasis Management Market Definitions
2.2.1. By Product Type
2.2.2. By Disease
2.2.3. By Administration
2.2.4. By Distribution Channel
2.2.5. By Region
3. Global Canine Leishmaniasis Management Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Canine Leishmaniasis Management Market Dynamic Factors - Impact Analysis
3.6. Global Canine Leishmaniasis Management Market Competition Landscape
4. Global Canine Leishmaniasis Management Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Canine Leishmaniasis Management Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. Vaccines
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) & (Volume, Units)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Antibiotics
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Polyene antibiotics (Amphotericin B)
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Marbofloxacin
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Miltefosine
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Meglumine Antimoniate
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Pentavalent antimonials
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Allopurinol combinations
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Paromomycin
5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
6. Global Canine Leishmaniasis Management Market Forecast, By Disease, 2019 - 2023 and Forecast, 2024 - 2030
6.1. Visceral leishmaniasis
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Cutaneous leishmaniasis
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Mucocutaneous leishmaniasis
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Canine Leishmaniasis Management Market Forecast, By Administration, 2019 - 2023 and Forecast, 2024 - 2030
7.1. Oral
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Parenteral
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Topical
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Canine Leishmaniasis Management Market Forecast, By Application, 2019 - 2023 and Forecast, 2024 - 2030
8.1. Veterinary Clinics
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Veterinary Pharmacies
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Online Pharmacies
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. NGOs
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Others
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. Global Canine Leishmaniasis Management Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Canine Leishmaniasis Management Market - Opportunity Analysis Index, By Product Type, By Disease, By Administration, By Distribution Channel and Region 2024 - 2030
10. North America Canine Leishmaniasis Management Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Vaccines
10.1.2. Antibiotics
10.1.3. Polyene Antibiotics (Amphotericin B)
10.1.4. Marbofloxacin
10.1.5. Miltefosine
10.1.6. Meglumine Antimoniate
10.1.7. Pentavalent Antimonials
10.1.8. Allopurinol Combinations
10.1.9. Paromomycin
10.1.10. Others
10.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Visceral leishmaniasis
10.2.2. Cutaneous leishmaniasis
10.2.3. Mucocutaneous leishmaniasis
10.3. Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Oral
10.3.2. Parenteral
10.3.3. TopicalSkin
10.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Veterinary Clinics
10.4.2. Veterinary Pharmacies
10.4.3. Online Pharmacies
10.4.4. NGOs
10.4.5. Others
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Canine Leishmaniasis Management Market - Opportunity Analysis Index, By Product Type, By Disease, By Administration, By Distribution Channel and Country, 2024 - 2030
10.7. North America Canine Leishmaniasis Management Market Dynamics Trends
11. Europe Canine Leishmaniasis Management Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
11.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Vaccines
11.1.2. Antibiotics
11.1.3. Polyene Antibiotics (Amphotericin B)
11.1.4. Marbofloxacin
11.1.5. Miltefosine
11.1.6. Meglumine Antimoniate
11.1.7. Pentavalent Antimonials
11.1.8. Allopurinol Combinations
11.1.9. Paromomycin
11.1.10. Others
11.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Visceral leishmaniasis
11.2.2. Cutaneous leishmaniasis
11.2.3. Mucocutaneous leishmaniasis
11.3. Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Oral
11.3.2. Parenteral
11.3.3. TopicalSkin
11.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Veterinary Clinics
11.4.2. Veterinary Pharmacies
11.4.3. Online Pharmacies
11.4.4. NGOs
11.4.5. Others
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Canine Leishmaniasis Management Market - Opportunity Analysis Index, By Product Type, By Disease, By Administration, By Distribution Channel and Country, 2024 - 2030
11.7. Europe Canine Leishmaniasis Management Market Dynamics – Trends
12. Asia-Pacific Canine Leishmaniasis Management Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
12.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Vaccines
12.1.2. Antibiotics
12.1.3. Polyene Antibiotics (Amphotericin B)
12.1.4. Marbofloxacin
12.1.5. Miltefosine
12.1.6. Meglumine Antimoniate
12.1.7. Pentavalent Antimonials
12.1.8. Allopurinol Combinations
12.1.9. Paromomycin
12.1.10. Others
12.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Visceral leishmaniasis
12.2.2. Cutaneous leishmaniasis
12.2.3. Mucocutaneous leishmaniasis
12.3. Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Oral
12.3.2. Parenteral
12.3.3. TopicalSkin
12.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Veterinary Clinics
12.4.2. Veterinary Pharmacies
12.4.3. Online Pharmacies
12.4.4. NGOs
12.4.5. Others
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Canine Leishmaniasis Management Market - Opportunity Analysis Index, By Product Type, By Disease, By Administration, By Distribution Channel and Country, 2024 - 2030
12.7. Asia-Pacific Canine Leishmaniasis Management Market Dynamics Trends
13. Latin America Canine Leishmaniasis Management Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
13.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Vaccines
13.1.2. Antibiotics
13.1.3. Polyene Antibiotics (Amphotericin B)
13.1.4. Marbofloxacin
13.1.5. Miltefosine
13.1.6. Meglumine Antimoniate
13.1.7. Pentavalent Antimonials
13.1.8. Allopurinol Combinations
13.1.9. Paromomycin
13.1.10. Others
13.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Visceral leishmaniasis
13.2.2. Cutaneous leishmaniasis
13.2.3. Mucocutaneous leishmaniasis
13.3. Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Oral
13.3.2. Parenteral
13.3.3. TopicalSkin
13.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Veterinary Clinics
13.4.2. Veterinary Pharmacies
13.4.3. Online Pharmacies
13.4.4. NGOs
13.4.5. Others
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Canine Leishmaniasis Management Market - Opportunity Analysis Index, By Product Type, By Disease, By Administration, By Distribution Channel and Country, 2024 - 2030
13.7. Latin America Canine Leishmaniasis Management Market Dynamics  Trends
14. Middle East and Africa Canine Leishmaniasis Management Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
14.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Vaccines
14.1.2. Antibiotics
14.1.3. Polyene Antibiotics (Amphotericin B)
14.1.4. Marbofloxacin
14.1.5. Miltefosine
14.1.6. Meglumine Antimoniate
14.1.7. Pentavalent Antimonials
14.1.8. Allopurinol Combinations
14.1.9. Paromomycin
14.1.10. Others
14.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Visceral leishmaniasis
14.2.2. Cutaneous leishmaniasis
14.2.3. Mucocutaneous leishmaniasis
14.3. Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Oral
14.3.2. Parenteral
14.3.3. TopicalSkin
14.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Veterinary Clinics
14.4.2. Veterinary Pharmacies
14.4.3. Online Pharmacies
14.4.4. NGOs
14.4.5. Others
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Canine Leishmaniasis Management Market - Opportunity Analysis Index, By Product Type, By Disease, By Administration, By Distribution Channel and Country, 2024 - 2030
14.7. MEA Canine Leishmaniasis Management Market Dynamics Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Zoetis, Inc. (Pfizer) (U.S)
15.2.2. Ceva Sant Animale (Hertape Calier Saude Animal S.A)
15.2.3. Virbac AH Inc. (France)
15.2.4. Laboratories Leti (Spain)
15.2.5. Bioiberica S.A. (Spain)
15.2.6. Sanofi S.A. (France)
16. Research Methodology
17. Key Assumptions and Acronyms
  • Zoetis, Inc. (Pfizer) (U.S)
  • Hertape Calier Saude Animal S.A. (Brazil)
  • Virbac AH Inc. (France)
  • Laboratories Leti (Spain)
  • Bioiberica S.A. (Spain)
  • Sanofi S.A. (France)

Adjacent Markets